Modification of haemophiliac haemorrhage pain by transcutaneous electrical nerve stimulation

Patricia A. Roche, Karel Gijsbers, Jill J. F. Belch, Charles D. Forbes

    Research output: Contribution to journalArticle

    21 Citations (Scopus)

    Abstract

    Haemophiliacs suffer considerable pain when they bleed into their joints. This study investigated the use of transcutaneous electrical nerve stimulation (TENS) for relief of such pain. Thirty-six haemophiliac patients received either active or placebo TENS treatment. The intensity of pain was assessed before and after treatment using the McGill Pain Questionnaire. After 25 min of active treatment, 71% of the subjects reported at least 50% pain relief as measured by the McGill Pain Questionnaire. This compares with only 25% pain relief experienced by the placebo group.
    Original languageEnglish
    Pages (from-to)43-48
    Number of pages6
    JournalPain
    Volume21
    Issue number1
    DOIs
    Publication statusPublished - 1985

    Fingerprint

    Transcutaneous Electric Nerve Stimulation
    Hemorrhage
    Pain
    Pain Measurement
    Placebos
    Therapeutics
    Joints

    Cite this

    Roche, Patricia A. ; Gijsbers, Karel ; Belch, Jill J. F. ; Forbes, Charles D. / Modification of haemophiliac haemorrhage pain by transcutaneous electrical nerve stimulation. In: Pain. 1985 ; Vol. 21, No. 1. pp. 43-48.
    @article{d508bce39df645e38ba527b8cee8bdd9,
    title = "Modification of haemophiliac haemorrhage pain by transcutaneous electrical nerve stimulation",
    abstract = "Haemophiliacs suffer considerable pain when they bleed into their joints. This study investigated the use of transcutaneous electrical nerve stimulation (TENS) for relief of such pain. Thirty-six haemophiliac patients received either active or placebo TENS treatment. The intensity of pain was assessed before and after treatment using the McGill Pain Questionnaire. After 25 min of active treatment, 71{\%} of the subjects reported at least 50{\%} pain relief as measured by the McGill Pain Questionnaire. This compares with only 25{\%} pain relief experienced by the placebo group.",
    author = "Roche, {Patricia A.} and Karel Gijsbers and Belch, {Jill J. F.} and Forbes, {Charles D.}",
    year = "1985",
    doi = "10.1016/0304-3959(85)90075-2",
    language = "English",
    volume = "21",
    pages = "43--48",
    journal = "Pain",
    issn = "0304-3959",
    publisher = "Lippincott, Williams & Wilkins",
    number = "1",

    }

    Modification of haemophiliac haemorrhage pain by transcutaneous electrical nerve stimulation. / Roche, Patricia A.; Gijsbers, Karel; Belch, Jill J. F.; Forbes, Charles D.

    In: Pain, Vol. 21, No. 1, 1985, p. 43-48.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Modification of haemophiliac haemorrhage pain by transcutaneous electrical nerve stimulation

    AU - Roche, Patricia A.

    AU - Gijsbers, Karel

    AU - Belch, Jill J. F.

    AU - Forbes, Charles D.

    PY - 1985

    Y1 - 1985

    N2 - Haemophiliacs suffer considerable pain when they bleed into their joints. This study investigated the use of transcutaneous electrical nerve stimulation (TENS) for relief of such pain. Thirty-six haemophiliac patients received either active or placebo TENS treatment. The intensity of pain was assessed before and after treatment using the McGill Pain Questionnaire. After 25 min of active treatment, 71% of the subjects reported at least 50% pain relief as measured by the McGill Pain Questionnaire. This compares with only 25% pain relief experienced by the placebo group.

    AB - Haemophiliacs suffer considerable pain when they bleed into their joints. This study investigated the use of transcutaneous electrical nerve stimulation (TENS) for relief of such pain. Thirty-six haemophiliac patients received either active or placebo TENS treatment. The intensity of pain was assessed before and after treatment using the McGill Pain Questionnaire. After 25 min of active treatment, 71% of the subjects reported at least 50% pain relief as measured by the McGill Pain Questionnaire. This compares with only 25% pain relief experienced by the placebo group.

    U2 - 10.1016/0304-3959(85)90075-2

    DO - 10.1016/0304-3959(85)90075-2

    M3 - Article

    VL - 21

    SP - 43

    EP - 48

    JO - Pain

    JF - Pain

    SN - 0304-3959

    IS - 1

    ER -